Kimberly Levasseur F (@KLFrx) profile picture

Kimberly Levasseur F

@KLFrx

Critical care pharmacist, neurocritical care, clinical manager, mom , wifey

Joined October 2017
  • Tweets1.5K
  • Following526
  • Followers434
206Media
Photo by Kimberly Levasseur F (@KLFrx)Photo by Kimberly Levasseur F (@KLFrx)Photo by Kimberly Levasseur F (@KLFrx)Photo by Kimberly Levasseur F (@KLFrx)Photo by Kimberly Levasseur F (@KLFrx)Photo by Kimberly Levasseur F (@KLFrx)Photo by Kimberly Levasseur F (@KLFrx)Photo by Kimberly Levasseur F (@KLFrx)Photo by Kimberly Levasseur F (@KLFrx)Photo by Kimberly Levasseur F (@KLFrx)
#NCSPharmJC The study population
Image from Kimberly Levasseur F (@KLFrx)
1
33
more replies
#NCSpharmJC @karenccrx @ETNCCRX @AJWPharm Impact to practice? Per Dr. Wendel
Image from Kimberly Levasseur F (@KLFrx)
1
20
Final take away points -
Image from Kimberly Levasseur F (@KLFrx)
10
#NCSPharmJC
Image from Kimberly Levasseur F (@KLFrx)
1
30
more replies
Who was included/excluded?
Image from Kimberly Levasseur F (@KLFrx)
2
10
#NCSpharmJC Methodology of the medications and monitoring:
Image from Kimberly Levasseur F (@KLFrx)
11
What was studied? #NCSpharmJC @karenccrx @ETNCCRX @AJWPharm
Image from Kimberly Levasseur F (@KLFrx)
7
Onto the next journal article discussion! #NCSPharmJC
Image from Kimberly Levasseur F (@KLFrx)
1
1
22
Why is this a problem - let's remember what DDVP can do... @karenccrx @ETNCCRX @AJWPharm
Image from Kimberly Levasseur F (@KLFrx)
1
16
You may remember reading...
Image from Kimberly Levasseur F (@KLFrx)
10
#NCSPharmJC @karenccrx @ETNCCRX @AJWPharm What about safety
Image from Kimberly Levasseur F (@KLFrx)
1
1
206
more replies
#NCSPharmJC Where should we go from here?
Image from Kimberly Levasseur F (@KLFrx)
1
10
Dr. Parsons' Take away: OPTION is unique in focusing specifically on non-large vessel occlusion strokes; whereas TRACE-III focused on LVO without thrombectomy and HOPE included mixed vessel populations.
20
Load more